Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)

Por Schneider, Bryan P, O'Neill, Anne, Shen, Fei, Sledge, George W, Thor, Ann D, Kahanic, Stephen P, Zander, Paul J, Davidson, Nancy E
Publicado no Br J Cancer (2015)

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemothera...

Por Steensma, David P., Sloan, Jeff A., Dakhil, Shaker R., Dalton, Robert, Kahanic, Stephen P., Prager, Diane J., Stella, Philip J., Rowland, Kendrith M., Novotny, Paul J., Loprinzi, Charles L.
Publicado em 2011

Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N03CB)(...

Por Jatoi, Aminah, Rowland, Kendrith, Sloan, Jeff A., Gross, Howard M., Fishkin, Paul A., Kahanic, Stephen P., Novotny, Paul J., Schaefer, Paul L., Johnson, David B., Tschetter, Loren K., Loprinzi, Charles L.
Publicado em 2008

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cel...

Por Durie, Brian G M, Hoering, Antje, Abidi, Muneer H, Rajkumar, S Vincent, Epstein, Joshua, Kahanic, Stephen P, Thakuri, Mohan, Reu, Frederic, Reynolds, Christopher M, Sexton, Rachael, Orlowski, Robert Z, Barlogie, Bart, Dispenzieri, Angela
Publicado no Lancet (2016)

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast can...

Por Perez, E. A., Hillman, D. W., Dentchev, T., Le-Lindqwister, N. A., Geeraerts, L. H., Fitch, T. R., Liu, H., Graham, D. L., Kahanic, S. P., Gross, H. M., Patel, T. A., Palmieri, F. M., Dueck, A. C.
Publicado em 2010